SUPRAN BRYAN
EVP, CLO and Secretary
SUPRAN BRYAN has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Oct 6, 2026.
On the most recent filing, SUPRAN BRYAN is listed as EVP, CLO and Secretary at ALNYLAM PHARMACEUTICALS, INC. Inside the rolling window, SUPRAN BRYAN reported no open-market purchases and 1 open-market sale totaling $399K in ALNY.
Companies traded
Other insiders at ALNY
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$399K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has SUPRAN BRYAN made?
SUPRAN BRYAN has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does SUPRAN BRYAN trade?
SUPRAN BRYAN has filed SEC Form 4 disclosures for 1 company, including ALNY.
When was SUPRAN BRYAN's most recent SEC Form 4 filing?
SUPRAN BRYAN's most recent SEC Form 4 filing on Tracefour is dated Oct 6, 2026.
What is SUPRAN BRYAN's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, SUPRAN BRYAN is listed as EVP, CLO and Secretary.
What is SUPRAN BRYAN's total buy and sell value in the current window?
Inside the rolling retention window, SUPRAN BRYAN bought $0 and sold $399K based on SEC Form 4 filings.
What was SUPRAN BRYAN's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,758 ALNY shares on 2026-10-02, worth $399K, per SEC Form 4 filings.